Literature DB >> 6618683

Effect of chemotherapy and reinfection on IgE-containing and IgG-containing circulating immune complexes, serum IgE and IgE antibodies in patients chronically infected with Schistosoma mansoni and Schistosoma haematobium.

H Feldmeier, W J Stevens, C H Bridts, A A Daffalla, D W Büttner.   

Abstract

The effect of chemotherapy and reinfection on circulating immune complexes (CIC), serum IgE, and parasite-specific IgE antibodies was studied in patients concomitantly infected with Schistosoma mansoni and Schistosoma haematobium. Before chemotherapy IgE- and IgG-containing CIC were present in high concentrations in all patients and IgE antibodies to S. mansoni and to S. haematobium in almost 80% of the cases. Serum IgE was excessively high (median 4,900 ku/1), but decreased to half of its initial value 2 months after chemotherapy. When reinfection with S. haematobium occurred onwards from month 4, the serum IgE reincreased and reached almost the pretreatment level at month 16. Effective chemotherapy was also followed by a rapid decrease of IgE-containing CIC and a slower, but significant, decrease of IgG-containing CIC. However, in contrast to IgE and IgE antibodies, the reinfection did not lead to a reincrease of CIC. It was interesting to note that the concentration of IgE as well as that of IgE-containing CIC was significantly correlated to the intensity of the infection. These investigations demonstrated that high levels of IgE- and IgG-containing CIC are present in chronic human schistosomiasis, but that the concentrations of CIC fall to normal values, when the parasites are eliminated by chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6618683     DOI: 10.1159/000234870

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  6 in total

1.  Schistosomiasis: progress and problems.

Authors:  George Y Wu; Mohab H Halim
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Effect of praziquantel on certain immune responses of schistosomal Egyptian patients. I. Changes of specific immunoglobulins.

Authors:  Z A Shaker; H I Hassanein; M M Kamel; N M el-Bahairy; A H el-Kalouby; E H el-Raziky
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

3.  Antibodies of the IgE and IgG isotype, serum IgE and circulating immune complexes in schistosomiasis intercalatum.

Authors:  K Zwingenberger; H Feldmeier; W J Stevens; A Steiner
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

4.  Relationship between intensity of infection and immunomodulation in human schistosomiasis. I. Lymphocyte subpopulations and specific antibody responses.

Authors:  H Feldmeier; G A Gastl; U Poggensee; C Kortmann; A A Daffalla; H H Peter
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

5.  Reactivity of IgE in human Schistosoma mansoni sera to S. mansoni antigens.

Authors:  G Reiner; H Zahner
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

6.  Prospective European-wide multicentre study on a blood based real-time PCR for the diagnosis of acute schistosomiasis.

Authors:  Dominic Wichmann; Sven Poppert; Heidrun Von Thien; Joannes Clerinx; Sebastian Dieckmann; Mogens Jensenius; Philippe Parola; Joachim Richter; Mirjam Schunk; August Stich; Philipp Zanger; Gerd D Burchard; Egbert Tannich
Journal:  BMC Infect Dis       Date:  2013-01-30       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.